Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for PONV in Pediatric Dental Rehabilitation
NCT05124067Phase 1Completed
- Sponsor
- Tanta University
- Start
- Oct 2021
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of dexmedetomidine in postoperative nausea and vomiting (PONV) (4 arms), sponsored by Tanta University. Primary endpoint: Number of participants who will develop postoperative nausea and vomiting and rate of development at 24 hours. Started Oct 2021; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT05124067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05124067.